Does TOFACITINIB Cause Maternal exposure during pregnancy? 3,981 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 3,981 reports of Maternal exposure during pregnancy have been filed in association with TOFACITINIB (XELJANZ XR). This represents 2.6% of all adverse event reports for TOFACITINIB.
3,981
Reports of Maternal exposure during pregnancy with TOFACITINIB
2.6%
of all TOFACITINIB reports
1,185
Deaths
1,495
Hospitalizations
How Dangerous Is Maternal exposure during pregnancy From TOFACITINIB?
Of the 3,981 reports, 1,185 (29.8%) resulted in death, 1,495 (37.6%) required hospitalization, and 1,428 (35.9%) were considered life-threatening.
Is Maternal exposure during pregnancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 3,981 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Maternal exposure during pregnancy?
CERTOLIZUMAB PEGOL (9,013)
ADALIMUMAB (7,518)
PREDNISONE (6,587)
METHOTREXATE (6,223)
RITUXIMAB (6,093)
INFLIXIMAB (6,061)
HYDROXYCHLOROQUINE (5,809)
FOLIC ACID (5,768)
TOCILIZUMAB (5,737)
LEFLUNOMIDE (5,643)
Which TOFACITINIB Alternatives Have Lower Maternal exposure during pregnancy Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN